Perioperative use of metformin in cardiac surgery;Metformino vartojimas širdies chirurgijoje perioperaciniu laikotarpiu

Medicina

Volumn 46, Issue 11, 2010, Pages 723-729

  Širvinskas, Edmundas ^a   Kinduris, Šarunas ^a   Kapturauskas, Juozas ^a   Samalavičius, Robertas ^b  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^b VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Diabetes mellitus; Heart surgery; Lactic acidosis; Metformin

Indexed keywords

EID: 79954489104     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina46110102     Document Type: Review

References (41)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Diabetes Care 2004;27:1047-53.
2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-31.
3. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004;109:1497-502.
4. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002;359:2140-4.
5. Conaway DG, O'Keefe JH, Reid KJ, Spertus J. Frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome. Am J Cardiol 2005;96(3):363-5.
6. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005;111:3078-86.
7. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.
8. Dembo AJ, Marliss EB, Halperin ML. Insulin therapy in phenformin-associated lactic acidosis: a case report, biochemical considerations and review of the literature. Diabetes 1975;24:28-35.
9. Holstein A, Stumvoll M. Contraindications can damage your health - is metformin a case in point? Diabetologia 2005;8:2454-9.
10. Luft FC. Lactic acidosis update for critical care clinicians. J Am Soc Nephrol 2001;12 Suppl 17:S15-9.
11. Sirtori CR, Pasik C. Re-evaluation of a biguanide metform-in: mechanism of action and tolerability. Pharmacol Res 1994;30:187-228.
12. Alberti K, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23: 469-80.
13. Douek IF, Allen SE, Ewings P, Gale EA, Bingley PJ, the Metformin Trial Group. Continuing metformin when starting insulin in patients with Type 2 diabetes: a double-blind randomized placebo-controlled trial. Diabet Med 2005; 22:634-40.
14. Deutsche Diabetes-Gesellschaft. Evidenzbasierte Leitlinie: Antihyperglykämische Therapie des Diabetes mellitus Typ 2. (German Diabetes Association. Evidence-based guidelines: antihyperglicemic therapy for type 2 diabetes melli-tus.) Diabetes und Stoffwechsel 2003;12:13-31.
15. Glucophage 500 mg/-850 mg/-1000 mg (package insert). Darmstadt, Germany, Merck; 2005.
16. British National Formulary No. 49 (March 2005) 6.1.2.2. Metformin Hydrochloride.
17. DuBose TD. Acidosis and alkalosis. In: Fauci AS, editor. Harrison's principles of internal medicine. New York: McGraw-Hill; 2005; p. 263-71.
18. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996; 334(9):574-9.
19. Blyer S, Yelon J. The perioperative management of metformin for the oral and maxillofacial surgery patient: risks and recommendations. J Oral Maxillofac Surg 2007;65(1): 122-7.
20. Woods HF, Cohen R. Clinical and biochemical aspects of lactic acidosis. Oxford: Blackwell Scientific; 1976.
21. Brown JB, Pedula MS, Barzilay J, Herson MK, Latare P. Lactic acidosis rates in type 2 diabetes. Diabetes Care 1998; 21:1659-63.
22. Wilholm BE, Myrhed M. Metformin-associated lactic acidosis in Sweden 1977-1991. Eur J Clin Pharmacol 1993; 44:589-91.
23. Misbin RI, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming GA. Lactic acidosis in patients with diabetes treated with metformin (Letter). N Engl J Med 1998;338:265-6.
24. Sulkin TV, Bosman D, Krentz AJ. Contraindications to metformin therapy in patients with NIDDM. Diabetes Care 1997;20:925-8.
25. Emslie-Smith AM, Boyle DI, Evans JM, Sullivan F, Morris AD. Contraindications to metformin therapy in patients with type 2 diabetes - a population-based study of adherence to prescribing guidelines. Diabet Med 2001;18:483-8.
26. Holstein A, Nahrwold D, Hinze S, Egberts EH. Contraindications to metformin therapy are largely disregarded. Diabet Med 1999;16:692-6.
27. Lalau JD, Race JM. Lactic acidosis in metformin-treated patients: prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf 1999;20:377-84.
28. Cusi K, Consoli A, DeFronzo RA. Metabolic effects of metformin on glucose and lactate metabolism in non insulin-dependent diabetes mellitus. J Clin Endocrinol Metabol 1996;81:4059-67.
29. Salpeter S, Greyber E, Pasternak G, Salpeter E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2003; (2): CD002967.
30. Salpeter S, Greyber E, Pasternak G, Salpeter E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2006; (1): CD002967.
31. Stades AM, Heikens JT, Erkelens DW, Holleman F, Hoekstra JB. Metformin and lactic acidosis: cause or coincidence? A review of case reports. J Intern Med 2004;255:179-87.
32. Brassøe R, Elkmann T, Hempel M, Gravholt CH. Fulminant lactic acidosis in two patients with Type 2 diabetes treated with metformin. Diabet Med 2005;22(10):1451-3.
33. Gowardman JR, Havill J. Fatal metformin induced lactic acidosis: case report. N Z Med J 1995;108:230-1.
34. Mercker SK, Maier C, Neumann G, Wulf H. Lactic acidosis as a serious perioperative complication of antidiabetic bi-guanide medication with metformin. Anesthesiology 1997; 87:1003-5.
35. Duncan AI, Koch CG, Xu M, Manlapaz M, Batdorf B, Pitas G, et al. Recent metformin ingestion does not increase inhospital morbidity or mortality after cardiac surgery. Anesth Analg 2007;104:42-50.
36. Manlapaz MR, Duncan AI, Koch CG, Xu M, Starr NJ. Diabetic patients treated with metformin have decreased pulmonary morbidity following cardiac surgery. Anesthesiol-ogy 2005;103:A326.
37. McAfee AT, Koro C, Landon J, Ziyadeh N, Walker AM. Coronary heart disease outcomes in patients receiving antidiabetic agents. Pharmacoepidemiol Drug Saf 2007;16(7): 711-25.
38. Hoekstra JBL, Holleman F, DeVries H. Glucose tolerance testing in patients scheduled for cardiovascular surgery. Semin Cardiothorac Vasc Anesth 2006;10(1):7-9.
39. Mears SC, Lipsett PA, Brager MD, Riley LH. Metformin-associated lactic acidosis after elective cervical spine fusion. Spine 2002;27(22):E482-4.
40. Alberti KGMM, Phil D. Diabetes and surgery. Anesthesiology 1991;74:209-11.
41. Lustik SJ, Vogt A, Chhibber AK. Postoperative lactic acidosis in patients receiving metformin. Anesthesiology 1998; 89:266.